We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Declining Comps Likely to Hurt Fred's (FRED) in Q3 Earnings
Read MoreHide Full Article
Fred’s Inc is slated to report third-quarter fiscal 2017 results on Dec 6, before the opening bell.
We note that Fred’s delivered losses in the past five quarters. Further, the company has been struggling with murky comparable-store sales (comps).
While the company has a mixed record of bottom-line surprises in the trailing four quarters, let’s look into how things are shaping up for the upcoming announcement.
What to Expect?
The Zacks Consensus Estimate for the third quarter of fiscal 2017 is pegged at a loss of 15 cents, which has widened by a penny over the past 30 days. However, estimated loss for the quarter under review is lower than the prior year adjusted loss of 27 cents.
Also, analysts polled by Zacks expect revenues of $500.5 million, down 3.1% from the year-ago period.
Fred’s has been delivering dismal comps since past many quarters, owing to declining traffic trends, sale of low productive discontinued inventory and rise in generic dispensing rate. Additionally, the company’s store expansion plans were gravely impacted by the cancelled Walgreens Boots Alliance (WBA - Free Report) and Rite Aid Corporation merger in June 2017. Had the deal materialized, Fred’s would have emerged as the third-largest drugstore chain in the nation after Walgreens and CVS Health Corporation (CVS - Free Report) .
We note that comparable store sales dipped 1.2% and 0.3% during the first and second quarters of fiscal 2017. The company’s weak comps trend is likely to continue in the third quarter as well.
Nevertheless, Fred’s has been advancing with initiatives to reduce selling, general and administrative expenses and boost free cash flow. Further, the company has been trying to organize pharmacy business to drive scripts into the stores and improve service to its patients. Although such efforts seem promising, they are yet to bear significant impacts upon the company’s performance.
What Does the Zacks Model Unveil?
Our proven model does not conclusively show that Fred’s is likely to beat earnings estimates this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. You may uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce ""the world's first trillionaires,"" but that should still leave plenty of money for regular investors who make the right trades early.
Image: Bigstock
Declining Comps Likely to Hurt Fred's (FRED) in Q3 Earnings
Fred’s Inc is slated to report third-quarter fiscal 2017 results on Dec 6, before the opening bell.
We note that Fred’s delivered losses in the past five quarters. Further, the company has been struggling with murky comparable-store sales (comps).
While the company has a mixed record of bottom-line surprises in the trailing four quarters, let’s look into how things are shaping up for the upcoming announcement.
What to Expect?
The Zacks Consensus Estimate for the third quarter of fiscal 2017 is pegged at a loss of 15 cents, which has widened by a penny over the past 30 days. However, estimated loss for the quarter under review is lower than the prior year adjusted loss of 27 cents.
Also, analysts polled by Zacks expect revenues of $500.5 million, down 3.1% from the year-ago period.
Fred's, Inc. Price, Consensus and EPS Surprise
Fred's, Inc. Price, Consensus and EPS Surprise | Fred's, Inc. Quote
Factors Impacting the Quarter
Fred’s has been delivering dismal comps since past many quarters, owing to declining traffic trends, sale of low productive discontinued inventory and rise in generic dispensing rate. Additionally, the company’s store expansion plans were gravely impacted by the cancelled Walgreens Boots Alliance (WBA - Free Report) and Rite Aid Corporation merger in June 2017. Had the deal materialized, Fred’s would have emerged as the third-largest drugstore chain in the nation after Walgreens and CVS Health Corporation (CVS - Free Report) .
We note that comparable store sales dipped 1.2% and 0.3% during the first and second quarters of fiscal 2017. The company’s weak comps trend is likely to continue in the third quarter as well.
Nevertheless, Fred’s has been advancing with initiatives to reduce selling, general and administrative expenses and boost free cash flow. Further, the company has been trying to organize pharmacy business to drive scripts into the stores and improve service to its patients. Although such efforts seem promising, they are yet to bear significant impacts upon the company’s performance.
What Does the Zacks Model Unveil?
Our proven model does not conclusively show that Fred’s is likely to beat earnings estimates this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. You may uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Although Fred’s carries a Zacks Rank #3, its Earnings ESP of 0.00% makes surprise prediction difficult. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce ""the world's first trillionaires,"" but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>